Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Kraker

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Protocols|February 6, 2023
Ensuring Full Spectrum Flow Cytometry Data Quality for High-Dimensional Data AnalysisLaura Ferrer-Font, Geoffrey Kraker, Kathryn E Hally, et al.
Blood|January 15, 2011
Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AMLJames Marvin, Suchitra Swaminathan, Geoffrey Kraker, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 20, 2022
Full spectrum flow cytometry and mass cytometry: A 32-marker panel comparisonMaria C Jaimes, Michael Leipold, Geoffrey Kraker, et al.
Nature Communications|February 18, 2022
Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learningYvonne M Mueller, Thijs J Schrama, Rik Ruijten, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Protocols|February 6, 2023
Ensuring Full Spectrum Flow Cytometry Data Quality for High-Dimensional Data AnalysisLaura Ferrer-Font, Geoffrey Kraker, Kathryn E Hally, et al.
Blood|January 15, 2011
Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AMLJames Marvin, Suchitra Swaminathan, Geoffrey Kraker, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 20, 2022
Full spectrum flow cytometry and mass cytometry: A 32-marker panel comparisonMaria C Jaimes, Michael Leipold, Geoffrey Kraker, et al.
Nature Communications|February 18, 2022
Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenotyping and machine learningYvonne M Mueller, Thijs J Schrama, Rik Ruijten, et al.
Pageof 1